US Patent 8008307 Heteroaryl compounds useful as inhibitors of E1 activating enzymes

Patent 8008307 was granted and assigned to Millennium Pharmaceuticals on August, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Millennium Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

80083070

Patent Inventor Names

Steven P. Langston0

Stepan Vyskocil0

Stephane Peluso0

Stephen Critchley0

Christopher F. Claiborne0

Courtney Cullis0

Edward J. Olhava0

Gabriel S. Weatherhead0

...

Date of Patent

August 30, 2011

Patent Application Number

118903380

Date Filed

August 6, 2007

Patent Primary Examiner

‌

Deepak Rao

Patent abstract

This invention relates to compounds that inhibit E1 activating enzymes, pharmaceutical compositions comprising the compounds, and methods of using the compounds. The compounds are useful for treating disorders, particularly cell proliferation disorders, including cancers, inflammatory and neurodegenerative disorders; and inflammation associated with infection and cachexia.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8008307 Heteroaryl compounds useful as inhibitors of E1 activating enzymes

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API